Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that preferentially binds to α1A receptors found in the prostate, bladder neck, and urethra, promoting smooth muscle relaxation and increasing urinary flow.
## Primary Indications
* Signs and symptoms of Benign Prostatic Hyperplasia (BPH).
* Off-label: Medical Expulsive Therapy (MET) for ureteral calculi.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, 30 minutes after the same meal each day.
* **Maximum Dose:** 0.8 mg daily. If no response after 2–4 weeks at 0.4 mg, the dose may be increased to 0.8 mg once daily.
* **Ureteral Calculi (Off-label):** 0.4 mg orally once daily for up to 4 weeks.
## Pediatric Dosing
* **Not indicated** for pediatric use. Efficacy and safety have not been established in the pediatric population.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment indicated for patients with mild to moderate impairment. Use caution in severe renal impairment (CrCl <10 mL/min).
* **Hepatic Impairment:** Not recommended in patients with severe hepatic impairment (Child-Pugh class C). No adjustment needed for mild to moderate impairment.
## Contraindications
* Hypersensitivity to tamsulosin or any component of the formulation.
## Adverse Effects
* **Common:** Dizziness, headache, ejaculation disorder (retrograde ejaculation), rhinitis, orthostatic hypotension.
* **Serious:** Syncope (especially with the first dose), intraoperative floppy iris syndrome (IFIS) during cataract surgery, priapism, and angioedema.
## Key Drug Interactions
* **CYP3A4/2D6 Inhibitors:** Strong inhibitors (e.g., ketoconazole, clarithromycin) can significantly increase tamsulosin exposure. Avoid or reduce dose to 0.4 mg if concomitant use is required.
* **Antihypertensives/PDE5 Inhibitors:** Concomitant use increases the risk of additive hypotensive effects or symptomatic orthostasis.
* **Cimetidine:** May decrease the clearance of tamsulosin.
## Monitoring
* Monitor blood pressure periodically, particularly in the elderly or those on concurrent antihypertensives.
* Monitor for symptom improvement (e.g., IPSS score) and signs of orthostatic hypotension.
* Assure patients planning cataract surgery inform their ophthalmologist of tamsulosin use.
## Clinical Pearls
* **Administration:** It is critical to take the medication 30 minutes after the *same* meal daily to ensure consistent pharmacokinetics and minimize adverse events.
* **First Dose:** The risk of syncope is highest following the first dose or dose escalation. Advise patients to rise slowly from a sitting or lying position.
* **Sulfa Allergy:** Use caution in patients with a history of sulfonamide allergy, as cross-reactivity is theoretically possible, though uncommon.
* **Prostate Cancer:** Rule out prostate cancer prior to initiating therapy, as symptoms of BPH and prostate cancer overlap.
***
*Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult current institutional protocols, prescribing leaflets, and clinical databases (e.g., Lexicomp or Micromedex) to verify dosing, interactions, and contraindications before prescribing or administering medication.*
